Substance P enhances collagen remodeling and MMP-3 expression by human tenocytes

Journal of Orthopaedic Research

Volumn 31, Issue 1, 2013, Pages 91-98

  Fong, Gloria ^a,b,c,d   Backman, Ludvig J ^b   Hart, David A ^c,e   Danielson, Patrik ^b   McCormack, Bob ^c   Scott, Alex ^a,c  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UMEÅ UNIVERSITY   (Sweden)

^c VANCOUVER COASTAL HEALTH   (Canada)

^d UNIVERSITY OF SYDNEY   (Australia)

^e UNIVERSITY OF CALGARY   (Canada)

Author keywords

collagen; myofibroblasts; neurokinin 1 receptor; tendinopathy; tendinosis

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; ALPHA2 INTEGRIN; COLLAGEN; COLLAGEN TYPE 1; COLLAGEN TYPE 3; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERSTITIAL COLLAGENASE; MESSENGER RNA; NEUROKININ 1 RECEPTOR; STROMELYSIN; SUBSTANCE P; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ARTICLE; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IN VITRO STUDY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TENDON; TENOCYTE; TENSILE STRENGTH;

ACHILLES TENDON; ACTINS; BIOPSY; COLLAGEN TYPE I; COLLAGEN TYPE III; FIBROBLASTS; GENE EXPRESSION; HUMANS; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 3; NEUROTRANSMITTER AGENTS; PRIMARY CELL CULTURE; RECEPTORS, NEUROKININ-1; SUBSTANCE P; TENDINOPATHY; TISSUE INHIBITOR OF METALLOPROTEINASE-1; WEIGHT-BEARING;

EID: 84870254838     PISSN: 07360266     EISSN: 1554527X     Source Type: Journal    
DOI: 10.1002/jor.22191     Document Type: Article

References (24)

1. Khan KM, Cook JL, Bonar F., et al. 1999. Histopathology of common tendinopathies. Update and implications for clinical management. Sports Med 27: 393-408.
2. Sivaguru M, Durgam S, Ambekar R., et al. 2010. Quantitative analysis of collagen fiber organization in injured tendons using Fourier transform-second harmonic generation imaging. Opt Express 24: 24983-24993.
3. Riley G., 2005. Chronic tendon pathology: molecular basis and therapeutic implications. Expert Rev Mol Med 5: 1-25.
4. Forsgren S, Alfredson H, Bjur D, et al. 2009. Novel information on the non-neuronal cholinergic system in orthopedics provides new possible treatment strategies for inflammatory and degenerative diseases. Orthop Rev (Pavia) 1: e11.
5. Bjur D, Danielson P, Alfredson H, et al. 2008. Presence of a non-neuronal cholinergic system and occurrence of up- and down-regulation in expression of M2 muscarinic acetylcholine receptors: new aspects of importance regarding Achilles tendon tendinosis (tendinopathy). Cell Tissue Res 2: 385-400.
6. Andersson G, Danielson P, Alfredson H, et al. 2008. Presence of substance P and the neurokinin-1 receptor in tenocytes of the human Achilles tendon. Regul Pept 1-3: 81-87.
7. Andersson G, Backman LJ, Scott A, et al. 2011. Substance P accelerates hypercellularity and angiogenesis in tendon tissue and enhances paratendinitis in response to Achilles tendon overuse in a tendinopathy model. Br J Sports Med 13: 1017-1022.
8. Steyaert A, Burssens P, Forsyth R, et al. 2010. Qualitative analysis of substance P, NK1-receptor and nerve ingrowth in substance P-treated ruptured rat Achilles tendon. Acta Orthop Belg 3: 387-395.
9. Lui PP, Chan LS, Fu SC, et al. 2010. Expression of sensory neuropeptides in tendon is associated with failed healing and activity-related tendon pain in collagenase-induced tendon injury. Am J Sports Med 4: 757-764.
10. Burssens P, Steyaert A, Forsyth R, et al. 2005. Exogenously administered substance P and neutral endopeptidase inhibitors stimulate fibroblast proliferation, angiogenesis and collagen organization during Achilles tendon healing. Foot Ankle Int 10: 832-839.
11. Carlsson O, Schizas N, Li J, et al. 2011. Substance P injections enhance tissue proliferation and regulate sensory nerve ingrowth in rat tendon repair. Scand J Med Sci Sports 4: 562-569.
12. Hart DA, Reno C., 1998. Pregnancy alters the in vitro responsiveness of the rabbit medial collateral ligament to neuropeptides: effect on mRNA levels for growth factors, cytokines, iNOS, COX-2, metalloproteinases and TIMPs. Biochim Biophys Acta 1408: 35-43.
13. Hart DA, Kydd A, Reno C., 1999. Gender and pregnancy affect neuropeptide responses of the rabbit Achilles tendon. Clin Orthop Relat Res 365: 237-246.
14. Backman LJ, Fong G, Andersson G, et al. 2011. Substance P is a mechanoresponsive, autocrine regulator of human tenocyte proliferation. PLoS One 11: e27209.
15. Reno C, Marchuk L, Sciore P, et al. 1997. Rapid isolation of total RNA from small samples of hypocellular, dense connective tissues. Biotechniques 6: 1082-1086.
16. Lui PPY, Chan LS, Fu SC, et al. 2010. Expression of sensory neuropeptides in tendon is associated with failed healing and activity-related tendon pain in collagenase-induced tendon injury. Am J Sport Med 4: 757-764.
17. Ireland D, Harrall R, Curry V, et al. 2001. Multiple changes in gene expression in chronic human Achilles tendinopathy. Matrix Biol 3: 159-169.
18. Jones GC, Corps AN, Pennington CJ, et al. 2006. Expression profiling of metalloproteinases and tissue inhibitors of metalloproteinases in normal and degenerate human Achilles tendon. Arthritis Rheum 3: 832-842.
19. Tomasek J, Rayan GM., 1995. Correlation of alpha-smooth muscle actin expression and contraction in Dupuytren's disease fibroblasts. J Hand Surg Am 3: 450-455.
20. Tsuzaki M, Bynum D, Almekinders L, et al. 2003. ATP modulates load-inducible IL-1beta, COX 2, and MMP-3 gene expression in human tendon cells. J Cell Biochem 3: 556-562.
21. Parreno J, Buckley-Herd G, de-Hemptinne I, et al. 2008. Osteoblastic MG-63 cell differentiation, contraction, and mRNA expression in stress-relaxed 3D collagen I gels. Mol Cell Biochem 1-2: 21-32.
22. Scott A, Cook JL, Hart DA, et al. 2007. Tenocyte responses to mechanical loading in vivo: a role for local insulin-like growth factor 1 signaling in early tendinosis in rats. Arth Rheum 3: 871-881.
23. Hinz B, Celetta G, Tomasek JJ, et al. 2001. Alpha-smooth muscle actin expression upregulates fibroblast contractile activity. Mol Biol Cell 9: 2730-2741.
24. Leivonen SK, Hakkinen L, Liu D, et al. 2005. Smad3 and extracellular signal-regulated kinase 1/2 coordinately mediate transforming growth factor-β-induced expression of connective tissue growth factor in human fibroblasts. J Invest Dermatol 6: 1162-1169.